skip to Main Content

Meet EASL's Social Media Advisor

Ahmed Elsharkawy

Read his bio

Dr Ahmed Elsharkawy has been a consultant transplant hepatologist at the Queen Elizabeth Hospital in Birmingham since 2012. He is also honorary senior lecturer at the University of Birmingham and a Fellow of the Royal College of Physicians of London.

His clinical interests include viral hepatitis, liver transplantation, polycystic liver disease, drug induced liver injury, primary biliary cirrhosis, acute liver failure, acute on chronic liver failure, NAFLD (especially in the context of hepatitis B) and cirrhotic sarcopaenia. He has pioneered novel approaches to the management of hepatitis C in the community.

He was awarded his PhD from Newcastle University on the role of NF-kB in the hepatic inflammation-fibrosis-cancer axis. He is a research active NHS clinician and is principle investigator on a number of clinical trials; as well as a member of trial steering committees.

He is the immediate past Chairman of the British Viral Hepatitis Group and has more than 60 peer reviewed publications. He is a regular peer reviewer for both publications and grants. He is keen on promoting the role of social media, in particular Twitter, in medical education and looking at novel ways to gain CME recognition through this.

Follow him on Twitter

Learn more and share your knowledge with the liver community
Join the Live Tweeting @EASLedu for each EASL meeting

4 Ways to Detox Your Liver and why you should start NOW! #LiverCancerAwarenessMonth #livercancer http://outbreaknewstoday.com/4-ways-to-detox-your-liver-and-why-you-should-start-now-80626/

"Treating patients w/ liver cancer is challenging. Some of the major risk factors tend to fall on those w/ reduced access to care, education, insurance & means. Providing for them is our daily mission." 💬 @MarioStrazzabos


October is #LiverCancerAwarenessMonth. Read more about liver cancer in sub-Saharan #Africa in our recent Series, which discusses the challenges faced in the region & the means by which the disease's poor outlook can be improved


#HCC #livertwitter

Back To Top